Endo, Inc. introduced its enhanced TruDelivery® platform, reinforcing its commitment to ready-to-administer and ready-to-use products. The TruDelivery website highlights the operational benefits and safety features of RTU products, including bivalirudin and dexmedetomidine injections, ephedrine sulfate premixed vials, PREVDUO® prefilled syringes, and VASOSTRICT® RTU bottles.
The TruDelivery® platform is accessible through a dedicated website, which serves as a comprehensive resource for healthcare professionals. It provides detailed information about the operational advantages and safety benefits associated with ready-to-use (RTU) products.
“As the name suggests, TruDelivery delivers—without mixing, compounding, or diluting—so our customers can focus on quality patient care,” said Scott Sims, Senior Vice President and General Manager, Injectable Solutions & Generics at Endo. “In addition to operational efficiencies, ready-to-administer and ready-to-use products may help reduce the risk of medication errors that can lead to unintended but catastrophic outcomes.
Image Credit: Endo, Inc.